SM
INSM icon

SG3 Management’s Insmed INSM Stock Holding History

SG3 Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,000
Closed -$300K – 89
2022
Q4 		$300K Buy
+15,000
New +$290K 0.04% 144
2021
Q3 		– Sell
-30,000
Closed -$854K – 1114
2021
Q2 		$854K Buy
+30,000
New +$890K 0.03% 512
2021
Q1 		– Sell
-15,000
Closed -$499K – 1328
2020
Q4 		$499K Hold
15,000
– – 0.01% 730
2020
Q3 		$482K Buy
+15,000
New +$431K 0.02% 577

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SG3 Management's INSM Position: Q3 2021 in Review

SG3 Management sold out of Insmed (INSM) in Q3 2021, closing a stake of 17,500 shares — an estimated $498K sold.

SG3 Management first reported a position in INSM in Q2 2021 and held it in 1 quarter. The position peaked at $498K in Q2 2021. 193 funds tracked by Wall St. Rank hold INSM as of Q3 2021.

  • SG3 Management reported no remaining Insmed position as of Q3 2021 after selling out during the quarter.
  • SG3 Management sold 17,500 Insmed shares in Q3 2021, an estimated $498K.
  • SG3 Management first reported a position in Insmed in Q2 2021 and held it in 1 quarter.
  • SG3 Management's Insmed position peaked at $498K in Q2 2021.
  • 193 funds tracked by Wall St. Rank held Insmed as of Q3 2021.

Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.